Loading provider…
Loading provider…
Cardiovascular Disease Physician in Los Angeles, CA
NPI: 1205028644Primary Practice Location
RONALD REAGAN UCLA MEDICAL CENTER
757 Westwood Plz, Los Angeles, CA
Primary Employer
UCLA Medical Plaza
uclahealth.org
HQ Phone
Get M.D. Eric's Phone Numberphone_androidMobile
Get M.D. Eric's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
2006 - 2025
CA State Medical License

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Cardiovascular Disease
Los Angeles County-Harbor-UCLA Medical Center
Fellowship • Cardiovascular Disease
2008 - 2011
Residency • Internal Medicine
2005 - 2008
University of Illinois College of Medicine - Chicago
medicine.uic.edu
Medical School
Until 2005
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 93306Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | 684 | 720 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 267 | 468 |
| 3 | 93325Doppler ultrasound study of color-directed heart blood flow, rate, and valve function | 95 | 103 |
| 4 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 87 | 223 |
| 5 | 99223Initial hospital inpatient care, typically 70 minutes per day | 75 | 78 |
Authors: Amir Lerman, Charanjit Rihal, Patricia Best
Journal: Eur Heart J
Publication Date: 2009-11-05
Authors: Purvi Parwani, Richard Bloomingdale, Joerg Herrmann, Dinu-Valentin Balanescu, Cezar Iliescu, Teodora Donisan
Journal: Rev Cardiovasc Med
Publication Date: 2022-06-24
Should the 'echo guidelines' be followed in cancer patients?
Authors: Herrmann, Joerg, Yang, Eric H
Journal: Future Oncol
Lead Sponsor: Janssen Research & Development, LLC
Collaborators: Bristol-Myers Squibb
Intervention / Treatment: OTHER: Placebo, DRUG: Milvexian
Lead Sponsor: Amgen
Collaborators: Colorado Prevention Center
Intervention / Treatment: DRUG: Routine Lipid Management, DRUG: Evolocumab
Lead Sponsor: Massachusetts General Hospital
Collaborators: Bristol-Myers Squibb
Intervention / Treatment: DRUG: Placebo, DRUG: Abatacept plus